To coincide with Cervical Cancer Prevention Week, QuantuMDx Group has announced the start of a field study with St George’s, University of London, to evaluate its human papilloma virus (HPV)
QuantuMDx is dedicated to making transformative, quality diagnostic technologies accessible to everyone, so that diseases can be detected and treated earlier, and transmission eradicated.
